13G Filing: Sabby Capital and Aytu Bioscience Inc (AYTU)

Page 3 of 9 – SEC Filing

6.
SHARED VOTING POWER 103,4157.
SOLE DISPOSITIVE POWER08.
SHARED DISPOSITIVE POWER 103,4159.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 103,41510.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)

[_]11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)2.1112.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

CO?

CUSIP No.
0547544031.
NAME OF REPORTING PERSONSSabby Management, LLC2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) [_]

(b) [X]

3.
SEC USE ONLY4.
CITIZENSHIP OR PLACE OF ORGANIZATIONDelaware, USANUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

5.
SOLE VOTING POWER06.
SHARED VOTING POWER 216,5427.
SOLE DISPOSITIVE POWER08.
SHARED DISPOSITIVE POWER 216,5429.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 216,54210.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)

[_]11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

Follow Aytu Biopharma Inc (NASDAQ:AYTU)